Scor SE
DUS:SDRC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Scor SE
DUS:SDRC
|
FR |
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
US |
|
A
|
Ansell Ltd
OTC:ANSLY
|
AU |
|
L
|
Lennar Corp
BMV:LEN
|
US |
|
Extendicare Inc
TSX:EXE
|
CA |
Intrinsic Value
Is SDRC undervalued or overvalued?
See the intrinsic value estimate for 
Scor SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
SDRC looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with SDRC’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Scor Does
Scor SE is a global reinsurance company. It sells insurance protection to other insurers and reinsurers, helping them share the risk from large losses such as natural disasters, accidents, and long-term life and health claims. In simple terms, Scor sits behind insurance companies and gives them a way to offload part of the risk they underwrite.
- Headquarters
- France FR
- Employees
- 3 610
- IPO date
- Jan 1, 1989
The intrinsic value for Scor SE (SDRC) under the Base Case is hidden EUR.
Compared with the current market price of 33.06 EUR, the stock appears hidden.